Pharmaceutical News

RSS

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.

23 Aug 2011

AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies

AstraZeneca today announced that BRILINTA tablets, a new oral antiplatelet therapy, is now available in pharmacies in the United States.

23 Aug 2011

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated today announced that Health Canada has approved INCIVEK tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.

23 Aug 2011

Drug co. executive gives pharma a sunny forecast

Severin Schwan thinks the skeptics are wrong. Those who shun the pharmaceutical sector for its lack of prospects don't understand the potential created by a rapidly growing understanding of genetics and molecular biology, and the new drugs that will follow. ... the chief executive of Roche Holding AG, the world's seventh-largest drug firm by sales, is an informed optimist.

22 Aug 2011

Modified Ecstasy could be effective against cancer: Study

Researchers from Birmingham University have designed a drug similar to the illicit drug Ecstasy (3,4-methylenedioxymethamphetamine) that could be used to treat leukemia, lymphoma and myeloma after making it 100 times more effective at suppressing growth.

22 Aug 2011

New technique can detach sugars from carrier molecule, reattach them to drugs

The surface of cells and many biologically active molecules are studded with sugar structures that are not used to store energy, but rather are involved in communication, immunity and inflammation.

22 Aug 2011

Decline in HT use could lead to lower mammogram rates among women

A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.

22 Aug 2011

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

Today AIDS Healthcare Foundation (AHF) decried the fact that the recent campaign by Gilead Sciences Inc. to obtain approval by the U.S. Food & Drug Administration for Truvada as PrEP (pre-exposure prophylaxis) has led to a "black market" for the drug in Florida.

20 Aug 2011

VOA News examines new drug compound that shows broad-based efficacy in lab tests

VOA News looks at a new drug compound developed by researchers at the Massachusetts Institute of Technology (MIT) that they say has so far "killed every virus it's been tested on in the laboratory." "The drug - known by the acronym DRACO - works by chemically targeting viral-infected cells and prompting them to self-destruct, eliminating the disease in the process," VOA writes.

20 Aug 2011

FDA accepts Alexza ADASUVE NDA, assigns PDUFA action date

Alexza Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has accepted the ADASUVE New Drug Application (NDA) as a complete, class 2 response to the FDA's action letter, with an indicated Prescription Drug User Fee Act (PDUFA) goal date of February 4, 2012.

20 Aug 2011

EBD Group, MassBio announce plenary sessions program for BioPharm America 2011

EBD Group and MassBio today announced the plenary sessions program for BioPharm America 2011, being held at the Westin Boston Waterfront Hotel, September 7-9.

20 Aug 2011

Statin therapy may not be appropriate for certain patients at risk for stroke

For many patients, cholesterol-lowering statin drugs can reduce the risk of strokes as well as heart attacks.

20 Aug 2011

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

The corpus delicti is a plain flacon from among the possessions of Pharaoh Hatshepsut, who lived around 1450 B.C., which is on exhibit in the permanent collection of the Egyptian Museum of the University of Bonn. For three and a half millennia, the vessel may have held a deadly secret. This is what the Head of the collection, Michael H-veler-M-ller and Dr. Helmut Wiedenfeld from the university's Pharmacology Institute just discovered.

20 Aug 2011

Combination of exercise and metformin less effective for people with diabetes

It's common enough for researchers to look at the impacts of prescribed drugs on the body. And if you're a diabetes researcher who believes that exercise has great benefits for those with type 2 diabetes, you're hoping your research will show that. But when Normand Boul- looked at the dual impacts of exercise and metformin - two of the most commonly-prescribed modalities for glucose control - on that very outcome, the hoped-for double whammy wasn't the result.

20 Aug 2011

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen.

20 Aug 2011

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.

20 Aug 2011

High levels of calcium in coronary arteries increase risk of stroke, heart attack

The presence of calcium in coronary arteries is a much better predictor of heart attack and stroke than C-reactive protein among people with normal levels of LDL cholesterol, according to a study of more than 2,000 people led by a Johns Hopkins heart specialist.

19 Aug 2011

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.

19 Aug 2011

Cannabis Science enters distribution agreement with PVM for marijuana dispensing machines

Cannabis Science, Inc., a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that Cannabis Science has entered into an exclusive distribution Agreement with Prescription Vending Machines Inc. ("PVM") and contracted with PVM's principal Vincent Mehdizadeh to provide industry specific consulting and advisory services to Cannabis Science.

19 Aug 2011

Only 15 U.S. pharmaceutical ads adhere to FDA Prescription Drug Advertising Guidelines

A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements in biomedical journals found that only 18 percent were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.

19 Aug 2011

Pharmaceutical News

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Drug co. executive gives pharma a sunny forecast

Modified Ecstasy could be effective against cancer: Study

New technique can detach sugars from carrier molecule, reattach them to drugs

Decline in HT use could lead to lower mammogram rates among women

AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida

VOA News examines new drug compound that shows broad-based efficacy in lab tests

FDA accepts Alexza ADASUVE NDA, assigns PDUFA action date

EBD Group, MassBio announce plenary sessions program for BioPharm America 2011

Statin therapy may not be appropriate for certain patients at risk for stroke

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Combination of exercise and metformin less effective for people with diabetes

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

High levels of calcium in coronary arteries increase risk of stroke, heart attack

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

Cannabis Science enters distribution agreement with PVM for marijuana dispensing machines

Only 15 U.S. pharmaceutical ads adhere to FDA Prescription Drug Advertising Guidelines

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News